Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting ...

Tectonic Therapeutic is a biotechnology company focused on the development of novel therapies for cardiovascular diseases, particularly those involving pulmonary hypertension and heart failure. Its ...

Heart disease is closely linked with obesity. Excess weight mainly accounts for the surge in deaths from cardiovascular ...

One in four adults in Bangladesh has hypertension, but only 14 percent manage to keep their blood pressure under control, according to the Bangladesh Hypertension Control Initiative under the ...

Discover how controlling blood pressure can protect your brain health, as groundbreaking research shows an impressive ...

Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

NHS bosses have issued an alert, urging certain people to "get checked". A post from the health service's official X account ...

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly diagnosed with pulmonary fibrosis feel supported during this time via a new ...

The trial's safety results were reassuring, with no serious adverse events or significant changes in vital signs, physical exams, or safety laboratory values post-administration of TX45. Transient ...

Shares of Tectonic Therapeutic (NASDAQ:TECX) added ~40% in the premarket on Thursday after the cardiac medicines developer ...